help button home button Endocrine Society JCEM ENDO 08
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 29, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2646
This Article
Right arrow Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Riepe, F. G.
Right arrow Articles by Holterhus, P.-M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riepe, F. G.
Right arrow Articles by Holterhus, P.-M.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Pediatric Endocrinology

Submitted on November 29, 2007
Accepted on April 22, 2008

Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing Congenital Adrenal Hyperplasia: Potential relevance of helix C for POR-CYP21 interaction

Felix G. Riepe*, Olaf Hiort, Joachim Grötzinger, Wolfgang G. Sippell, Nils Krone, and Paul-Martin Holterhus

Division of Pediatric Endocrinology, Department of Pediatrics, Christian-Albrechts-Universität zu Kiel, Germany (F.G.R., W.G.S., P.M.H.); Division of Pediatric Endocrinology, Department of Pediatrics, Universität zu Lübeck, Germany (O.H.); Biochemisches Institut, Christian-Albrechts-Universität zu Kiel, Germany (J.G.); Division of Medical Sciences, Institute of Biomedical Research, Endocrinology & Metabolism, University of Birmingham, United Kingdom (N.K.)

* To whom correspondence should be addressed. E-mail: friepe{at}pediatrics.uni-kiel.de.

Background: Congenital adrenal hyperplasia is caused by insufficient adrenal steroid biosynthesis due to impaired steroidogenic enzymes. The majority of patients suffers from deficiency of 21-hydroxylase (CYP21) coded by the CYP21A2 gene.

Objective: To study the functional and structural consequences of the novel CYP21A2 missense mutation c.364A>C (K121Q) detected in a female patient with nonclassical 21-hydroxylase deficiency. The patient was compound heterozygous for the novel K121Q mutation and the mild P453S mutation.

Results: In vitro expression analysis of the mutant K121Q enzyme in transiently transfected COS-7 cells revealed reduced CYP21 activity of 14.0 ± 5% for the conversion of 17-hydroxyprogesterone and 19.5 ± 4% for the conversion of progesterone. K121 is located on helix C in the CYP21 protein, which is part of the heme coordinating system. In addition helix C is involved in the interaction with the electron providing enzyme P450 oxidoreductase. Protein modelling revealed that the substitution of glutamine for the basic amino acid lysine introduces an electrostatic change on the surface of CYP21 and may additionally change heme coordination. We hypothesize that the electron flux between POR and CYP21 is impaired and, moreover, substrate affinity is altered due to heme dislocation with K121Q.

Conclusion: Both, the interaction of POR and CYP21 as well as heme coordination are likely to be disturbed due to the K121Q mutation. Our data exemplify how the combination of in vitro expression and structural protein analysis provide novel insights into molecular mechanisms of reduced CYP21 activity eventually explaining the patient's phenotype.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society